Skip Navigation
Skip to contents

JLC : Journal of Liver Cancer



Page Path
HOME > J Liver Cancer > Volume 16(1); 2016 > Article
Case Report Complete Response of Single Nodular Large Hepatocellular Carcinoma with Pulmonary Metastasis by Sequential Transarterial Chemoembolization and Sorafenib: A Case Report
Gi-Hyun Kim, Hyung-Min Yu, Chae-June Lim, Sung-Bum Cho
Journal of Liver Cancer 2016;16(1):47-51
Published online: March 31, 2016
Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea
  • 4 Download
  • 0 Crossref
  • 0 Scopus

Current guidelines recommend sorafenib as the first-line molecular target agent for advanced hepatocellular carcinoma (HCC) with extrahepatic metastasis and unresectable HCC. Sorafenib was reported to show survival benefit for patients with advanced HCC. However, complete response is extremely rare in patients treated with sorafenib. Here, we report a 52-year-old man with advanced HCC and pulmonary metastasis who showed complete response by sequential transarterial chemoembolization and continuous sorafenib. Complete response was sustained for 53-month until now.

JLC : Journal of Liver Cancer